|
WDR5B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.97540000415708E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.38970000016248E-07 |
| Normal-vs-Stage2 |
4.281200E-03 |
| Normal-vs-Stage3 |
7.436600E-01 |
| Normal-vs-Stage4 |
1.149810E-01 |
| Stage1-vs-Stage2 |
3.194400E-01 |
| Stage1-vs-Stage3 |
3.420400E-03 |
| Stage1-vs-Stage4 |
6.857400E-01 |
| Stage2-vs-Stage3 |
8.357800E-03 |
| Stage2-vs-Stage4 |
8.528600E-01 |
| Stage3-vs-Stage4 |
1.541550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00319999979592E-08 |
| Normal-vs-AfricanAmerican |
3.555500E-04 |
| Normal-vs-Asian |
7.414600E-01 |
| Caucasian-vs-AfricanAmerican |
5.560600E-01 |
| Caucasian-vs-Asian |
1.654630E-01 |
| AfricanAmerican-vs-Asian |
2.432600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63719999779488E-08 |
| Normal-vs-Female |
3.154400E-04 |
| Male-vs-Female |
2.858400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.860110E-03 |
| Normal-vs-Extreme_Weight |
5.72420000000129E-05 |
| Normal-vs-Obese |
2.169500E-04 |
| Normal-vs-Extreme_Obese |
7.290000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.953600E-01 |
| Normal_Weight-vs-Obese |
9.379000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.875000E-01 |
| Extreme_Weight-vs-Obese |
9.563400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.933600E-01 |
| Obese-vs-Extreme_Obese |
7.260400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.156600E-04 |
| Normal-vs-Age(41-60Yrs) |
8.4936999655838E-09 |
| Normal-vs-Age(61-80Yrs) |
1.98468000000007E-05 |
| Normal-vs-Age(81-100Yrs) |
3.177400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.053200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.733000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.743600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.003550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.202980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.262200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73505654288419E-12 |
| Normal-VS-Type2 PRCC |
9.452800E-01 |
| Normal-VS-KIRP CIMP |
5.165000E-01 |
| Normal-VS-Unclassified PRCC |
2.742400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.25464091840877E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.988370E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.596300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.039600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.818110E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.591200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.964500E-03 |
| Normal-vs-N1 |
2.331800E-01 |
| Normal-vs-N2 |
4.602800E-01 |
| N0-vs-N1 |
8.902000E-01 |
| N0-vs-N2 |
7.296800E-01 |
| N1-vs-N2 |
6.310800E-01 |
|
|
